글렘웨이
| 출원번호 | 40-2026-0217533 |
|---|---|
| 상태 | 출원 |
| 출원일 | 2026-10-16 |
| 상품류 | 제5류 |
지정상품
제5류
- 간질환 치료용 약제(Pharmaceutical preparations for the treatment of liver diseases)
- 당뇨병 치료용 약제(Pharmaceutical preparations for the treatment of diabetes)
- 신경계장애 치료용 약제(알코올 의존증/알츠하이머병을 포함/Pharmaceutical preparations for the treatment of neurological disorders, including alcohol dependence and alzheimer’s disease)
- 신경퇴행성 장애/질환 치료용 약제(Pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases)
- 심혈관질환/만성신장질환/심부전/고혈압 치료용 약제(Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension)
- 정신질환 치료용 약제(우울증/불안장애를 포함/Pharmaceutical preparations for the treatment of psychiatric disorders, including depression and anxiety)
- 체중감량/장기적 체중감소 유지용 약제(Pharmaceutical preparations for weight reduction and long term weight loss maintenance)